Experts question the government on how covacaine will work in Corona’s new strain

Advertisements

ICMR Director General on Sunday. Balaram Varghese says that covacin has caused a new virus infection in Britain and has the ability to deal with other strains. This is a major basis for vaccine approval.

Controversy has intensified over Corona’s indigenous vaccine, India Biotech Kovacin. Health experts have told the government on a scientific basis that India Biotech’s Covid-19 vaccine ‘Kovacin’ could be effective against a new strain of coronavirus and could be used as a “backup”. Experts have sought to disclose the scientific claims of the government and the safety and efficacy of the vaccine.

On Sunday, the country’s drug regulator, DCGI, approved the emergency use of Oxford-AstraZeneca’s Covishield and indigenous covacaine. However, not enough information is available about the efficacy and safety of Kovacin. Prominent virologist Shahid Jamil said that he did not believe that ‘Kovacin’ would eventually prove to be safe and would show more than 100 percent efficacy. He questioned the procedures adopted for vaccine approval and the statements of those in positions of responsibility.

Advertisements

The All India Drugs Action Network has also questioned the claim that ‘covacin’ could work better against a new strain of the virus, which is more contagious. Congress leaders Anand Sharma, Shashi Tharoor and Jairam Ramesh on Sunday expressed serious concern over the approval of the vaccine, saying it was “immature” and could prove dangerous.

Newsbip

On Sunday, the Director General of the Indian Council of Medical Research (ICMR) Dr. Balram Varghese says that Kovacin has been shown in Britain to have the ability to deal with other strains of the virus, including new strains. This is a major basis for vaccine approval. He acknowledged that no clear information was available on the effectiveness of the vaccine. AIIMS director Dr Randeep Guleria said the India biotech vaccine was only approved as a ‘backup’ in case of emergency. If the cases continue to grow, we may need more vaccines, but we can use the India Biotech vaccine. India Biotech Vaccine is much more backup. ‘

Listen to the latest songs, only at JioSaavn.com

Prime Time: Did the government backtrack on agricultural laws?

(This news is not edited by NDTV team. It is published directly from Syndicate feed))

Advertisements
Experts question the government on how covacaine will work in Corona’s new strain
Experts question the government on how covacaine will work in Corona’s new strain

We will be happy to hear your thoughts

Leave a Reply

NewsTree News - Latest News For You.
Logo